MC
María Cambra-Pellejà

Publications (1)

An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Article scientifique · 2022

Domaines principaux

Sciences de la santé1

Statistiques

Consultations0
Téléchargements0